Evidence map›Paper›PMID 24529992›Full record

ReviewChemistry & biology2014

Vitamin D metabolism, mechanism of action, and clinical applications.

Daniel D Bikle

Registry-linked trialOpen access · greenAbstract readReview
In one paragraph

Review in Chemistry & biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05269017 (The Potential Therapeutic Effect of Vitamin D Nasal Drops in the Treatment of Post COVID-19 Parosmia), which is not on this map. Cited by 880 papers, 11 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
880citing papers in PubMed, 11 pooled it
40.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05269017 phase2unknown statusnot on this mapstarted 2022, after this paper: background citation

The Potential Therapeutic Effect of Vitamin D Nasal Drops in the Treatment of Post COVID-19 Parosmia

TypeinterventionalSponsorMenoufia UniversityRan2022 to 2023Enrolled60ConditionsParosmiaArmsVitamin D3, Budesonide nasal spray
3 · Its place in the literature

Who cites it

880 citing papers in PubMed, 11 syntheses or guidelines pooled it, 1,839 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Trial
  13. Trial
  14. Trial
  15. Review
  16. Phosphate homeostasis and endocrine regulators.Pediatric nephrology (Berlin, Germany) · 2026
    Review
  17. Article
  18. Review
  19. Review
  20. Article

820 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Daniel D BikleVA Medical Center, Department of Medicine and Dermatology, University of California, San Francisco, San Francisco, CA 94121, USA. Electronic address: daniel.bikle@ucsf.edu.
San Francisco VA Medical Center · US

Funding

YEAST THREONINE &SERINE KINASESP41RR001614 · NCRR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ORTIZ DE MONTELLANO, PAUL R · 1985 to 2011
$24.1M
RELATIONSHIP OF PERMEABILITY BARRIER FUNCTION AND EPIDERMAL CYTOKINE PRODUCTIONP01AR039448 · NIAMS · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI ELIAS, PETER M · 1988 to 2007
$11.8M
Vitamin D Receptor Coactivators in KeratinocytesR01AR050023 · NIAMS · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI BIKLE, DANIEL DAVID · 2004 to 2014
$3.4M
VITAMIN D AND THE DIFFERENTIATION OF KERATINOCYTESR01AR038386 · NIAMS · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI BIKLE, DANIEL DAVID · 1987 to 2003
$1.1M
NCI NIH HHS CA 110338NCRR NIH HHS P41 RR001614NIAMS NIH HHS P01 AR039448NIAMS NIH HHS R01 AR038386NIAMS NIH HHS R01 AR050023
6 · The paper itself

Abstract

Vitamin D3 is made in the skin from 7-dehydrocholesterol under the influence of UV light. Vitamin D2 (ergocalciferol) is derived from the plant sterol ergosterol. Vitamin D is metabolized first to 25 hydroxyvitamin D (25OHD), then to the hormonal form 1,25-dihydroxyvitamin D (1,25(OH)2D). CYP2R1 is the most important 25-hydroxylase; CYP27B1 is the key 1-hydroxylase. Both 25OHD and 1,25(OH)2D are catabolized by CYP24A1. 1,25(OH)2D is the ligand for the vitamin D receptor (VDR), a transcription factor, binding to sites in the DNA called vitamin D response elements (VDREs). There are thousands of these binding sites regulating hundreds of genes in a cell-specific fashion. VDR-regulated transcription is dependent on comodulators, the profile of which is also cell specific. Analogs of 1,25(OH)2D are being developed to target specific diseases with minimal side effects. This review will examine these different aspects of vitamin D metabolism, mechanism of action, and clinical application.

Indexed as

Cytochrome P-450 Enzyme SystemDNAHumansImmune SystemMetabolic DiseasesNeoplasmsReceptors, CalcitriolResponse ElementsVitamin D1,25-dihydroxyvitamin DCytochrome P-450 Enzyme SystemDNAReceptors, CalcitriolVitamin D

Identifiers

PMID24529992
PMCPMC3968073
OpenAlexW1976776496

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.